Literature DB >> 2983073

Virus infections in immunocompromised patients: their importance and their management.

R N Sutton, R F Itzhaki, J Christophers, J Saldanha, A Gannicliffe, H Anderson.   

Abstract

Opportunistic viral infections were investigated in 156 adult patients admitted over one year to a medical oncology service: 35% of the total group and 65% of those with acute leukaemia experienced viral infections, 79% of which were with viruses of the herpes group. Surprisingly few enteric viruses were recovered. Reactivation of herpes simplex virus in the brains of these immunosuppressed patients was suggested by the demonstration by nucleic acid hybridization of herpes simplex virus DNA sequences in neurones and endothelial cells in patients with evidence of past infection with virus. Acyclovir was effective in therapy and prophylaxis. Twenty-three strains from 7 patients were tested for sensitivity to this antiviral: in 3 instances clinical resistance was observed but the strains were fully sensitive in vitro, as were all other strains tested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983073      PMCID: PMC1289576          DOI: 10.1177/014107688507800204

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  14 in total

1.  Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders.

Authors:  D L Aston; A Cohen; M A Spindler
Journal:  Br Med J       Date:  1972-11-25

2.  Tuberculin anergy and infectious mononucleosis.

Authors:  S Haider; M de L Coutinho; R T Emond; R N Sutton
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

3.  BWB759U, an analogue of acyclovir, inhibits human cytomegalovirus in vitro.

Authors:  A S Tyms; J M Davis; D J Jeffries; J D Meyers
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

4.  Isolation of virus from brain after immunosuppression of mice with latent herpes simplex.

Authors:  L Kastrukoff; C Long; P C Doherty; Z Wroblewska; H Koprowski
Journal:  Nature       Date:  1981-06-04       Impact factor: 49.962

5.  Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.

Authors:  J C Wade; C McLaren; J D Meyers
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

6.  Infectious gastroenteritis in bone-marrow-transplant recipients.

Authors:  R H Yolken; C A Bishop; T R Townsend; E A Bolyard; J Bartlett; G W Santos; R Saral
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

7.  Detection of herpes-simplex viral genome in brain tissue.

Authors:  L W Sequiera; L C Jennings; L H Carrasco; M A Lord; A Curry; R N Sutton
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

8.  Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.

Authors:  H J Field; G Darby; P Wildy
Journal:  J Gen Virol       Date:  1980-07       Impact factor: 3.891

9.  Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: a prospective study.

Authors:  M T Lam; G J Pazin; J A Armstrong; M Ho
Journal:  Cancer       Date:  1981-11-15       Impact factor: 6.860

10.  Transient immunodeficiency during asymptomatic Epstein-Barr virus infection.

Authors:  T J Bowen; R J Wedgwood; H D Ochs; W Henle
Journal:  Pediatrics       Date:  1983-06       Impact factor: 7.124

View more
  1 in total

1.  Herpes simplex virus, Candida albicans and mouth ulcers in neutropenic patients with non-haematological malignancy.

Authors:  G Beattie; J Whelan; J Cassidy; L Milne; S Burns; R Leonard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.